Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer

Autor: Wehn, Amy K., Qiu, Ping, Lunceford, Jared, Yarunin, Alexander, Cristescu, Razvan, Liu, Li, Roessler, Kyria, Bilke, Sven, Day, John R., Timms, Kirsten M., Weichert, Wilko, Marton, Matthew J.
Zdroj: In Gynecologic Oncology May 2024 184:67-73
Databáze: ScienceDirect
Externí odkaz: